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Abstract
During pregnancy, the energy requirements of the fetus impose changes in maternal metabolism. 
Increasing insulin resistance in the mother maintains nutrient flow to the growing fetus, while 
prolactin and placental lactogen counterbalance this resistance and prevent maternal 
hyperglycemia by driving expansion of the maternal population of insulin-producing β-cells1–3. 
However, the exact mechanisms by which the lactogenic hormones drive β-cell expansion remain 
uncertain. Here we show that serotonin acts downstream of lactogen signaling to drive β-cell 
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proliferation. Serotonin synthetic enzyme Tph1 and serotonin production increased sharply in β-
cells during pregnancy or after treatment with lactogens in vitro. Inhibition of serotonin synthesis 
by dietary tryptophan restriction or Tph inhibition blocked β-cell expansion and induced glucose 
intolerance in pregnant mice without affecting insulin sensitivity. Expression of the Gαq-linked 
serotonin receptor Htr2b in maternal islets increased during pregnancy and normalized just prior to 
parturition, while expression of the Gαi-linked receptor Htr1d increased at the end of pregnancy 
and postpartum. Blocking Htr2b signaling in pregnant mice also blocked β-cell expansion and 
caused glucose intolerance. These studies reveal an integrated signaling pathway linking β-cell 
mass to anticipated insulin need during pregnancy. Modulators of this pathway, including 
medications and diet, may affect the risk of gestational diabetes4.
Although lactogenic hormones regulate β-cell mass during pregnancy, they cannot alone 
explain all of the maternal changes in β-cell mass2,5–8. Despite persistent elevations of 
placental lactogen and prolactin through the end of pregnancy and the end of lactation, 
respectively, β-cell proliferation peaks at midgestation in rodents and drops to the normal 
non-pregnant rate or below by parturition, prompting rapid normalization of β-cell mass 
postpartum2,9,10 (Supplementary Fig. S1). Therefore, to identify other genes potentially 
involved in regulating maternal β-cell mass, we compared the global gene expression 
patterns in islets from non-pregnant and pregnant (G13 15) female mice by high-throughput 
sequencing of cDNA (Supplementary Table S1 and Supplementary Fig. S2.) and by 
hybridization to oligonucleotide microarrays (Supplementary Tables S2).
Among the genes most significantly induced during pregnancy were Tph1 and Tph2, which 
encode the two isoforms of tryptophan hydroxylase, the rate-limiting enzyme in the 
synthesis of serotonin (5-hydroxytryptamine, 5-HT). We have shown that β-cells share with 
serotonergic neurons a common gene expression program and the ability to synthesize, store 
and secrete serotonin (Y. Ohta and M. S. G., unpublished observations). Indeed, several 
other serotonergic transcripts were significantly increased in islets from pregnant mice, 
including those encoding aromatic L-amino acid decarboxylase, the enzyme that catalyzes 
the second and final step in serotonin synthesis, and vesicular monoamine transporter 
VMAT1 (Supplementary Table S1).
Real-time RT-PCR for Tph1 and Tph2 confirmed the genomic analyses (Fig. 1a). 
Expression of Tph1 and Tph2 increased from the non-pregnant baseline by gestational day 6 
(G6) and peaked at G12 with 527- and 7-fold increases respectively, while levels in gut, 
heart and brain did not change (Supplementary Fig. S3). Tph1 expression remained high 
postpartum until the end of lactation, followed by a return to pre-pregnancy levels. Specific 
antiserum against Tph1 demonstrated the induction of Tph1 protein in pregnant mouse islets 
by western blot11 (Fig. 1b). High performance liquid chromatography (HPLC) detected low 
tissue levels of 5-HT in islets of non-pregnant mice, which increased 420-fold in islets from 
pregnant animals, but did not change in gut (Fig. 1c, d).
RT-PCR amplified both Tph1 and Tph2 mRNA from β-cells purified from mice expressing 
eGFP in β-cells (MIP-GFP mice12) (Fig. 1e). Immunohistochemical staining detected 5-HT 
and TPH1 co-localized with insulin in islets from pregnant mice (Fig. 1f) and pregnant and 
post partum humans (Fig. 1g, h; Supplementary Fig. S3d). In a test of the ability of β-cells to 
Kim et al. Page 2
Nat Med. Author manuscript; available in PMC 2011 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
secrete this stored 5-HT, glucose stimulation induced secretion of insulin and 5-HT from 
islets isolated from pregnant mice (Fig. 1i, j).
Taken together, these data demonstrate that β-cells dramatically increase synthesis, storage 
and secretion of 5-HT during pregnancy. This increase may modestly boost circulating 5HT 
levels (Supplementary Fig. S4), but likely increases local islet levels of 5-HT much more. 
Therefore, we tested whether 5-HT affects β-cell function and glucose metabolism during 
pregnancy. Because tryptophan is an essential amino acid and the Km of Tph for tryptophan 
is higher than tissue tryptophan concentrations, dietary restriction of tryptophan can sharply 
drop 5-HT levels13. We found that mice fed a tryptophan-free diet from G6 to G12 and 
tested at G13 (Fig. 2a) developed severe glucose intolerance compared to mice fed either a 
normal or histidine-free diet (Fig. 2b). Furthermore, a less restricted diet, with 20% of 
normal tryptophan content, or treatment with the Tph inhibitor 4-chloro-DL-phenylalanine 
methyl ester hydrochloride (PCPA) also induced glucose intolerance in pregnant mice (Fig. 
2c), but not in non-pregnant female mice (Fig. 2d). These results support the conclusion that 
5-HT production is necessary for the maintenance of glucose homeostasis during pregnancy.
To determine how 5-HT might regulate islet function, we assayed the expression in islets of 
the 14 murine 5-HT receptors (Htr) by RT-PCR14. Several were expressed at relatively high 
levels in mouse islets (Fig. 2e), and transcripts encoding the Gαi-linked receptor Htr1d and 
the Gαq-linked receptor Htr2b were detected in purified β-cells (Fig. 2f). In pregnant mice, 
Htr2b expression increased significantly from G6 through G15 (Fig. 2g) and normalized at 
the end of gestation, while Htr1d expression increased at the end of gestation (G17) and 
postpartum (Fig. 2h). Interestingly, increased Htr2b expression closely correlated with the 
period of increased β-cell proliferation, and increased Htr1d expression correlated with the 
cessation of β-cell proliferation and regression of β-cell mass2,9.
To assess the contribution of 5-HT signaling, mice were treated with Htr antagonists (Fig. 
2a). Nonspecific Htr antagonist Methysergide and selective Htr2b antagonist SB204741 
induced glucose intolerance in pregnant mice (Fig. 2i), but not in non-pregnant female mice 
(SB204741, Fig. 2d) or when given acutely (Supplementary Fig. S5a), while selective Htr2a 
antagonist Ketanserin had no effect on glucose tolerance (Fig. 2i). Treatment with PCPA, 
SB204741, or a tryptophan-free diet all reduced insulin levels in pregnant mice (Fig. 2j), but 
insulin sensitivity was not reduced with PCPA or SB204741 (Supplementary Fig. S5b). To 
test genetically the requirement for Htr2b signaling during pregnancy, we assessed Htr2b 
null mice and observed glucose intolerance during pregnancy (Fig. 3a, b).
Given the known role of Htr2b signaling in driving cell proliferation in other tissues15–21, 
we tested whether 5-HT signaling contributes to increased β-cell proliferation during 
pregnancy. Treatment with PCPA or SB204741 as well as Htr2b loss reduced the normal 
increase in β-cell proliferation in pregnant mice at G13 as assayed by 5-bromo-2-
deoxyuridine (BrdU) incorporation (Fig. 2a, 3c), and prevented the pregnancy-induced 
expansion of β-cell mass (Fig 3d), but did not reduce insulin secretion acutely from islets in 
vitro (Supplementary Fig. S5c). In addition, both PCPA and SB204741 attenuated the 
growth of the MIN6 β-cell tumor line but not of NIH-3T3 fibroblasts (Supplementary Fig. 
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S6a). Therefore, expansion of β-cell mass during pregnancy requires both Tph1-driven 5-HT 
production and signaling through Htr2b.
To determine whether the requirement for Htr2b signaling resides specifically in the islets, 
we transplanted islets isolated from Htr2b+/+ or Htr2b−/− mice under the kidney capsule of 
Htr2b+/+ mice (Fig. 3e) and assessed β-cell proliferation in the transplanted islets during 
pregnancy. Although this approach removes the islets from their normal anatomic context, it 
avoids the use of cre-recombinase, which when expressed under the control of pancreatic 
promoters often recombines targeted genes in other tissues as well22. In transplanted β-cells, 
pregnancy induced 5-HT production regardless of the presence of Htr2b (Fig. 3f). However, 
while both the host and transplanted Htr2b+/+ β-cells similarly increased BrdU 
incorporation during pregnancy, fewer transplanted Htr2b−/− β-cells incorporated BrdU, 
demonstrating a local requirement for Htr2b signaling in islets during pregnancy (Fig. 3g, 
h).
Because pregnancy hormones prolactin and placental lactogen stimulate β-cell 
proliferation2,3,5,6, and prolactin induces Tph1 expression in the mammary gland23, we 
tested the ability of lactogenic hormones to induce Tph1 expression in islets isolated from 
pregnant mice at G3. Moderate concentrations of prolactin (200 ng ml−1) increased Tph1 
expression 28-fold, while high concentrations of prolactin (1,000 ng ml−1) corresponding to 
midgestation lactogen levels increased Tph1 expression by 147-fold (Fig. 4a) without 
affecting expression of Tph2, Htr1d or Htr2b (Fig. 4b–d). Human placental lactogen induced 
Tph1 expression to similar levels in G3 mouse islets, but non-pregnant islets responded less 
robustly (Supplementary Fig. S6d), consistent with evidence that prolactin receptor 
expression and signaling increase in islets early during pregnancy24 (Supplementary Table 
S1).
Next we tested whether 5-HT can independently induce islet cells to proliferate. Treatment 
of mouse islets with prolactin (1,000 ng ml−1) or 5-HT (10 μM) induced similar increases in 
proliferation as measured by BrdU incorporation (Fig. 4e) and Ki67 staining 
(Supplementary Fig. S6e). Finally, treatment of islets with 5-HT (10 μM) in vitro altered 
cyclin gene expression in a pattern similar to that seen in islets from pregnant mice (Fig. 4f, 
g).
Taken together, these studies suggest a simple model for the regulation of β-cell mass during 
pregnancy (Fig. 4h). During pregnancy, lactogenic signaling induces Tph1 expression and 5-
HT synthesis in islets. 5-HT in turn functions in a paracrine/autocrine fashion through Gαq-
coupled Htr2b to stimulate β-cell proliferation. Shortly before parturition, expression of 
Htr2b decreases and expression of Gαi-coupled Htr1d increases, generating an inhibitory 
signal capable of reducing β-cell proliferation and β-cell mass (M. Berger and M. S. G., 
unpublished data), so that β-cell mass returns rapidly to pre-pregnancy levels. While this 
model focuses on the regulation of β-cell mass, increasing evidence suggests that β-cell mass 
influences insulin production capacity and thus the risk of diabetes25–27. In addition, 
serotonin signaling may also directly impact insulin secretion independent of its effect on β-
cell mass. Finally, similar shifts in receptor expression could possibly contribute to other 
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peripartum changes, such as the mobilization of calcium from bone18 that occurs with 
lactation.
Modulators of this pathway, including drugs, diet and genetic inheritance, could impact the 
risk of gestational diabetes, and possibly the long term risk of developing type 2 diabetes. 
The dual roles of serotonin in regulating mood and β-cell mass provide a possible link that 
could explain the association of depression with both type 2 diabetes28 and gestational 
diabetes29, as well as the diabetogenic effects of some classes of psychiatric medications30. 
A more complete understanding of the function of this pathway may suggest improved 
methods for both preventing and treating diabetes.
Methods
C57BL/6J mice were housed on a 12-h light/dark cycle in climate-controlled, pathogen-free 
barrier facilities. The Institutional Animal Care and Use Committees at UCSF or Juntendo 
University approved all studies involving mice. Mating was confirmed by the presence of a 
vaginal plug the next morning, designated day 0 of gestation (G0). The control amino acid 
diet contained 0.2% tryptophan and 0.4% histidine, and the low tryptophan diet contained 
0.04% tryptophan. All drugs were administered by daily intraperitoneal injection except for 
BrdU, which was supplied in the drinking water at 1 mg ml−1.
Pancreatic islets were isolated from female mice by collagenase digestion, hand-picked and 
pooled. Glucose and insulin tolerance and insulin secretion tests were performed on fasting 
non-pregnant female or pregnant (G13) mice. Glucose and 5-HT levels were measured on 
whole blood, and insulin on plasma. Counting of BrdU positive β-cells and morphometric 
analyses were performed by serially sectioning the entire pancreas followed by staining and 
counting every 20th section. A minimum of 3,000 insulin positive cells were counted per 
pancreas. Human pancreatic tissue was obtained at autopsy at the UCSF Medical Center and 
Hirosaki University affiliated teaching hospitals. Details of tissue processing and staining, 
and RT-PCR assays are provided in Supplementary Materials.
All high-throughput sequencing data in this publication have been deposited in NCBI’s 
Gene Expression Omnibus and are accessible through GEO Series accession number 
GSE21860 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21860).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 5-HT production in islets during pregnancy
(a) mRNA levels for Tph1 and Tph2 measured by real time RT-PCR in islet RNA at the 
dates of gestation (G) or postpartum (P) indicated are shown relative to the levels in islets 
from non-pregnant female mice. n = 3 6 mice per data point. (b) Western blots were 
performed with Tph1 and β-actin antisera on protein extracted from islets of non-pregnant 
female (NP), pregnant (G12) and postpartum day 23 (P23) female mice and MIN6 
insulinoma cells. (c, d) Tissue 5-HT concentrations were assayed by HPLC in islets (c) and 
duodenum (d) isolated from 3 non-pregnant (NP) and 3 pregnant (G12) female mice. (e) The 
mRNA shown were amplified by RT-PCR from mouse islets, β-cells (GFP+), non-β islet 
cells (GFP−), brain, and the β-cell lines MIN6 and βTC3. (f) Immunofluorescent staining 
labels pancreata from non-pregnant female (Non-preg) and G12 pregnant mice with insulin 
and glucagon in green and 5-HT in red. (g) Immunoperoxidase staining labels 5-HT and 
TPH1 in pancreata from non-pregnant (Non-preg), pregnant (37 weeks gestation) and 
postpartum day 2 human autopsies. (h) Immunohistochemical co-staining labels insulin (red, 
fluorescent) and TPH1 (black, peroxidase) in pregnant human autopsy pancreas. (i, j) 
Secreted insulin (i) and 5-HT (j) was assayed by ELISA (i) and HPLC (j), following a 1 
hour incubation of islets isolated from pregnant (G13 G15) mice in 2 mM or 20 mM 
glucose. n = 5 groups of 40 islets. All data are presented as mean ± standard error. Statistical 
significance vs. islets cultured in 2mM glucose (i and j) or vs. non-pregnant control (a and c) 
was analyzed by Student’s t test: *, P < 0.05; **, P < 0.01; ***, P < 0.001. Scale bar 
indicates 20 μm.
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Figure 2. 5-HT signaling and glucose metabolism in pregnancy
(a) The treatment schedules for mouse experiments are shown. (b d) Blood glucose levels 
were measured after intraperotoneal injection of 2 g kg−1 glucose in pregnant mice (G13) 
fed a tryptophan-free (“Trp-free”, b), histidine-free (“His-free”, b) or low tryptophan (“Low 
Trp”, c) diet or treated with PCPA (300 mg kg−1 day−1)(c) or non-pregnant female mice (d) 
treated as shown. n = 5 18 mice per treatment group. (e) The Htr mRNAs shown were 
amplified by RT-PCR from mouse islet and brain RNA. (f) The mRNAs shown were 
amplified by RT-PCR from mouse islets, β-cells (GFP+), non-β islet cells (GFP−), brain, and 
β-cell lines MIN6 and βTC3. (g, h) mRNA levels for Htr2a and Htr2b (g) and Htr1b and 
Htr1d (h) measured by real time RT-PCR in islet RNA harvested at the gestational dates 
indicated are shown relative to the levels in islets from non-pregnant female mice. n = 3–6 
mice per data point. (i) Blood glucose levels were measured after intraperitoneal injection of 
glucose (2 g kg−1)in pregnant mice treated with SB204741 (1 mg kg−1 day−1), Methysergide 
(3 mg kg−1 day−1) or Ketanserin (1 mg−1 kg−1 day−1). n = 5 18 mice per treatment group. (j) 
Pregnant mice were treated as in Fig. 2a with tryptophan-free diet, PCPA or SB204741 and 
fasted for 6 hours at G13 before measuring insulin in plasma collected before and 30 
minutes after intraperitoneal injection of 2 g/kg glucose. n = 4 7 mice per group. All data are 
presented as mean ± standard error. Statistical significance vs. untreated control (b, c, i and 
j) or vs. non-pregnant control (g and h) was analyzed by Student’s t test: *, P < 0.05; **, P < 
0.01; ***, P < 0.001.
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Figure 3. Htr2b signaling and β-cell proliferation in pregnancy
(a, b) Blood glucose levels were measured after intraperitoneal injection of glucose (2 g 
kg−1) in pregnant (a) and non-pregnant (b) mice with the genotypes shown. n = 4 7 mice per 
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group. (c, d) In non-pregnant and pregnant control mice, pregnant mice treated with 
SB204741 or PCPA, and pregnant Htr2b−/− mice, β-cell proliferation (c) was quantified by 
counting the percent of insulin + cells labeled with BrdU, and relative β-cell mass (d) was 
calculated as the area of insulin + cells / total pancreatic area. n = 4 6 mice per group. (e) 
Islets isolated from Htr2b+/+ (black) or Htr2b−/− (red) mice were transplanted into the 
kidney capsule of Htr2b+/+ mice. (f) Immunofluorescent staining for 5-HT (red) and insulin 
(green) was performed on donor islets with the genotypes shown transplanted under the 
kidney capsule in non-pregnant or G13 pregnant hosts. (g) Immunofluorescent staining for 
insulin (red) and BrdU (green) together with DNA staining with DAPI (blue) was performed 
on host pancreatic islets and on donor islets with the genotypes shown transplanted under 
the kidney capsule in non-pregnant and G13 pregnant mice. (h) β-Cell proliferation in 
transplanted islets with the genotypes shown was quantified by counting the percent of 
insulin + cells labeled with BrdU in non-pregnant (NP) and pregnant mice. n = 3 4 per 
group. All data are presented as mean ± standard error. Statistical significance vs. Htr2b+/+ 
control (a), vs. pregnant untreated Htr2b+/+ control (c and d) or vs. pregnant Htr2b+/+ 
control (h) was analyzed by Student’s t test: *, P < 0.05; **, P < 0.01; ***, P < 0.001. Scale 
bar indicates 20 μm.
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Figure 4. 5-HT and lactogen induced β-cell proliferation
(a d) mRNA levels for Tph1 (a), Tph2 (b), Htr1d (c) and Htr2b (d) were measured by real-
time RT-PCR in RNA from islets isolated from G3 pregnant mice and cultured with the 
concentration of mouse prolactin (PRL) indicated for 72 hours. n = 3 6 per group. (e) β-Cell 
proliferation was quantified by counting the percent of insulin + cells labeled with BrdU in 
mouse islets cultured with prolactin (1,000 ng ml−1, PRL), 5-HT (10 μM) or no added 
hormone (control) for 4 days. n = 5 10 groups of islets per data point. (f, g) Levels of cyclin 
mRNAs were measured by real-time RT-PCR in RNA (f) from islets harvested at the dates 
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indicated and shown relative to the levels in control islets from non-pregnant female mice or 
(g) from islets cultured with 5-HT (10 μM) for the time indicated and shown relative to the 
levels in control islets cultured without 5-HT for 24 hours. n = 4 10 groups of islets per data 
point. (h) A proposed model is shown for 5-HT regulation of β-cell proliferation during 
pregnancy. All data are presented as mean ± standard error. Statistical significance vs. 
untreated control (a, e and g) or vs. non-pregnant control (f) was analyzed by Student’s t 
test: *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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